| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr13:50410600-50415000 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
| 2 |
chr13:50411200-50414600 |
Weak transcription |
iPS-18 Cell Line |
embryonic stem cell
|
| 3 |
chr13:50411400-50414600 |
Weak transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 4 |
chr13:50411400-50422000 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
| 5 |
chr13:50411600-50414600 |
Weak transcription |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
| 6 |
chr13:50412200-50415200 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
| 7 |
chr13:50412600-50415400 |
Enhancers |
HepG2 |
liver
|
| 8 |
chr13:50412800-50415000 |
Enhancers |
ES-WA7 Cell Line |
embryonic stem cell
|
| 9 |
chr13:50413000-50415200 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
| 10 |
chr13:50413000-50421600 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
| 11 |
chr13:50413200-50416000 |
Weak transcription |
Osteobl |
bone
|
| 12 |
chr13:50413400-50414600 |
Weak transcription |
Fetal Intestine Large |
intestine
|
| 13 |
chr13:50413400-50414800 |
Weak transcription |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
| 14 |
chr13:50413400-50418600 |
Weak transcription |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
| 15 |
chr13:50413600-50414600 |
Weak transcription |
Fetal Intestine Small |
intestine
|
| 16 |
chr13:50413600-50414800 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 17 |
chr13:50414200-50414600 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
| 18 |
chr13:50414200-50415000 |
Enhancers |
H1 Cell Line |
embryonic stem cell
|
| 19 |
chr13:50414200-50415000 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
| 20 |
chr13:50414200-50415000 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
| 21 |
chr13:50414200-50415200 |
Enhancers |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
| 22 |
chr13:50414200-50415200 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
| 23 |
chr13:50414200-50415400 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
| 24 |
chr13:50414400-50414600 |
Enhancers |
Right Atrium |
heart
|
| 25 |
chr13:50414400-50414600 |
Enhancers |
NH-A |
brain
|
| 26 |
chr13:50414400-50414800 |
Enhancers |
iPS-20b Cell Line |
embryonic stem cell
|
| 27 |
chr13:50414400-50414800 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
| 28 |
chr13:50414400-50415000 |
Enhancers |
HUES64 Cell Line |
embryonic stem cell
|
| 29 |
chr13:50414400-50415000 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
| 30 |
chr13:50414400-50415000 |
Enhancers |
Fetal Thymus |
thymus
|
| 31 |
chr13:50414400-50415000 |
Enhancers |
K562 |
blood
|
| 32 |
chr13:50414400-50415200 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
| 33 |
chr13:50414400-50415200 |
Enhancers |
iPS-15b Cell Line |
embryonic stem cell
|
| 34 |
chr13:50414400-50415600 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
